Publicacións en colaboración con investigadores/as de Charles University in Prague (18)

2024

  1. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  2. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

2022

  1. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 1, pp. 51-65

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 599-603

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study

    The Lancet Respiratory Medicine, Vol. 5, Núm. 8, pp. 627-638

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

    European Journal of Heart Failure, Vol. 18, Núm. 6, pp. 613-625

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 963-969

  2. Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity

    Acta Haematologica, Vol. 134, Núm. 4, pp. 215-228

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2012

  1. Human variome project country nodes: Documenting genetic information within a country

    Human Mutation, Vol. 33, Núm. 11, pp. 1513-1519

  2. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration

    Nature Genetics, Vol. 44, Núm. 6, pp. 704-708

2010

  1. Cardiac challenges in patients with Fabry disease

    International Journal of Cardiology, Vol. 141, Núm. 1, pp. 3-10